Who owns ABBOTT LABORATORIES (ABT)? Elite investor 13F holders

16 tracked elite investors reported holding ABBOTT LABORATORIES as of 2026-06-30, including GMO, D.E. Shaw, Jensen Investment Management, Renaissance Technologies LLC, Southeastern Asset Management. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.

16 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary…

Reported holders and securities, including exits (up to 20)

Reported holders and securities, including exits (up to 20)
InvestorSecurityInstrumentReport periodFiledValueQuantityUnitsChangeSource
GMOABBOTT LABORATORIESSHARE2026-06-302026-08-13 00:00:00797974712.00 USD8794077.000000SharesreduceOriginal filing
D.E. ShawABBOTT LABORATORIESSHARE2026-06-302026-08-14 00:00:00132261898.00 USD1457592.000000SharesreduceOriginal filing
Maverick CapitalABBOTT LABORATORIESSHARE2026-06-302026-08-14 00:00:000.00 USD0.000000SharesexitedOriginal filing
Jensen Investment ManagementABBOTT LABORATORIESSHARE2026-06-302026-08-07 00:00:0080328674.00 USD885262.000000SharesreduceOriginal filing
Renaissance Technologies LLCABBOTT LABORATORIESSHARE2026-06-302026-08-13 00:00:0062280851.00 USD686366.000000SharesreduceOriginal filing
Southeastern Asset ManagementABBOTT LABORATORIESSHARE2026-06-302026-08-14 00:00:0076289383.00 USD840747.000000SharesbuyOriginal filing
Mairs & Power FundsABBOTT LABORATORIESSHARE2026-06-302026-08-14 00:00:0066182014.00 USD729358.000000SharesaddOriginal filing
Tudor InvestmentABBOTT LABORATORIESSHARE2026-06-302026-08-14 00:00:0066270326.00 USD730332.000000SharesaddOriginal filing
Gotham Asset ManagementABBOTT LABORATORIESSHARE2026-06-302026-08-14 00:00:0044479024.00 USD490181.000000SharesaddOriginal filing
Bridgewater AssociatesABBOTT LABORATORIESSHARE2026-06-302026-08-14 00:00:005423983.00 USD59775.000000SharesreduceOriginal filing
Aristotle Capital ManagementABBOTT LABORATORIESSHARE2026-06-302026-08-14 00:00:004886984.00 USD53857.000000SharesreduceOriginal filing
Ancora Advisors / Ancora HoldingsABBOTT LABORATORIESSHARE2026-06-302026-08-14 00:00:004258012.00 USD46925.000000SharesreduceOriginal filing
Matrix Asset AdvisorsABBOTT LABORATORIESSHARE2026-06-302026-07-15 00:00:004288554.00 USD47262.000000SharesbuyOriginal filing
GAMCOABBOTT LABORATORIESSHARE2026-06-302026-08-12 00:00:001966427.00 USD21671.000000SharesreduceOriginal filing
Dodge & Cox FundsABBOTT LABORATORIESSHARE2026-06-302026-08-13 00:00:001571980.00 USD17324.000000SharesholdOriginal filing
Polen Capital ManagementABBOTT LABORATORIESSHARE2026-06-302026-08-04 00:00:00286379.00 USD3156.000000SharesreduceOriginal filing
Gardner Russo & QuinnABBOTT LABORATORIESSHARE2026-06-302026-08-13 00:00:001044417.00 USD11510.000000SharesholdOriginal filing

Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.

This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.

How to read the data · Disclaimer

Read as Markdown